Quince Therapeutics Inc.
13F holders, Q1 2024 (March 31)46holders
3famous investors
$1.06avg. 13F price*
At the end of Q1 2024, 46 institutions reported holding Quince Therapeutics Inc. in their 13F filings. The largest holders were Tang Capital Management LLC ($3.1M), Vanguard Group Inc. ($1.2M) and EPIQ Capital Group, LLC ($897K). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Quince Therapeutics Inc.
- CUSIP
- 22053A107
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $98K |
| Exits | 5 | $176K |
Ownership 46 holders
| Tang Capital Management LLC | 0.33% | Reduce -8.5% | 2,947,652 | $3.1M |
| Vanguard Group Inc. | 0.00% | Add +16.4% | 1,131,530 | $1.2M |
| EPIQ Capital Group, LLC | 0.36% | Reduce -2.8% | 845,773 | $897K |
| Renaissance Technologies | 0.00% | Add +13.4% | 520,100 | $551K |
| BlackRock Inc. | 0.00% | Reduce -1.1% | 332,086 | $352K |
| Geode Capital Management, LLC | 0.00% | Add +2.0% | 266,896 | $283K |
| Alphabet Inc. | 0.01% | No change | 189,122 | $200K |
| Bank of America Corp. | 0.00% | Reduce -0.1% | 169,901 | $180K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 138,495 | $147K |
| Two Sigma Advisers, LP | 0.00% | Reduce -11.7% | 97,100 | $103K |
| Susquehanna International Group, LLP | 0.00% | Reduce -3.3% | 96,782 | $103K |
| Scharf Investments, LLC | 0.00% | No change | 91,061 | $97K |
| Mariner, LLC | 0.00% | No change | 74,074 | $79K |
| State Street Corp. | 0.00% | No change | 56,611 | $60K |
| Intellectus Partners, LLC | 0.01% | Add +0.4% | 53,742 | $57K |
| Millennium Management | 0.00% | Reduce -9.7% | 53,679 | $57K |
| Northern Trust Corp. | 0.00% | Reduce -22.3% | 34,079 | $36K |
| ADAR1 Capital Management, LLC | 0.01% | New | 26,829 | $28K |
| Citadel Advisors | 0.00% | New | 26,456 | $28K |
| Ieq Capital, LLC | 0.00% | New | 22,523 | $24K |
| Kestra Advisory Services, LLC | 0.00% | New | 12,947 | $14K |
| Nixon Peabody Trust Co. | 0.00% | No change | 11,126 | $12K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 11,013 | $12K |
| Orion Porfolio Solutions, LLC | 0.00% | No change | 10,136 | $11K |
| Orion Portfolio Solutions, LLC | 0.00% | No change | 10,136 | $11K |
| Westmount Partners, LLC | 0.00% | Reduce -1.5% | 10,000 | $11K |
| Morgan Stanley | 0.00% | Reduce -7.6% | 8,400 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +7.8% | 7,278 | $8K |
| Citigroup Inc. | 0.00% | No change | 5,165 | $5K |
| Simplex Trading, LLC | 0.00% | Add +606.8% | 4,707 | $4K |
| Group One Trading LLC | 0.00% | New | 1,608 | $2K |
| FMR LLC | 0.00% | New | 1,500 | $2K |
| UBS Group AG | 0.00% | No change | 505 | $536 |
| JPMorgan Chase & Co. | 0.00% | No change | 469 | $497 |
| CoreCap Advisors, LLC | 0.00% | New | 431 | $457 |
| Rhumbline Advisers | 0.00% | No change | 394 | $417 |
| JDM Financial Group LLC | 0.00% | No change | 340 | $360 |
| Parallel Advisors, LLC | 0.00% | Reduce -86.9% | 311 | $330 |
| Financial Perspectives, Inc | 0.00% | No change | 310 | $329 |
| Osaic Holdings, Inc. | 0.00% | No change | 277 | $293 |
| Wells Fargo & Company | 0.00% | Reduce -78.8% | 268 | $284 |
| Financial Avengers, Inc. | 0.00% | No change | 100 | $109 |
| Barclays PLC | 0.00% | No change | 100 | $106 |
| Westside Investment Management, Inc. | 0.00% | No change | 75 | $80 |
| BNP Paribas Financial Markets | 0.00% | No change | 24 | $25 |
| Royal Bank of Canada | 0.00% | Add +68.7% | 221 | $0 |
"% of holder's portfolio" is QUINCE THERAPEUTICS INC's weight in each manager's 13F, not the share of Quince Therapeutics Inc. the manager owns.